Literature DB >> 3445395

Adrenomyeloneuropathy.

W Dickey, J A Lyttle, B B Sawhney, L Kennedy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3445395      PMCID： PMC2448255     

Source DB:  PubMed          Journal:  Ulster Med J        ISSN： 0041-6193


× No keyword cloud information.
  5 in total

1.  Adrenomyeloneuropathy: a probable variant of adrenoleukodystrophy. II. General pathologic, neuropathologic, and biochemical aspects.

Authors:  H H Schaumburg; J M Powers; C S Raine; P S Spencer; J W Griffin; J W Prineas; D M Boehme
Journal:  Neurology       Date:  1977-12       Impact factor: 9.910

2.  Adrenomyeloneuropathy: a probable variant of adrenoleukodystrophy. I. Clinical and endocrinologic aspects.

Authors:  J W Griffin; E Goren; H Schaumburg; W K Engel; L Loriaux
Journal:  Neurology       Date:  1977-12       Impact factor: 9.910

3.  Detection of adrenoleucodystrophy carriers by means of evoked potentials.

Authors:  J B Moloney; J G Masterson
Journal:  Lancet       Date:  1982-10-16       Impact factor: 79.321

4.  Adrenoleukodystrophy: survey of 303 cases: biochemistry, diagnosis, and therapy.

Authors:  H W Moser; A E Moser; I Singh; B P O'Neill
Journal:  Ann Neurol       Date:  1984-12       Impact factor: 10.422

5.  Adrenoleukodystrophy: increased plasma content of saturated very long chain fatty acids.

Authors:  H W Moser; A B Moser; K K Frayer; W Chen; J D Schulman; B P O'Neill; Y Kishimoto
Journal:  Neurology       Date:  1981-10       Impact factor: 9.910
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.